C48
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients who underwent cytoreductive surgery and/or HIPEC in the UKD (VTG) from 2013-2020 received cytoreductive surgery and/or HIPEC (regardless of underlying diagnosis).
Exclusion criteria
Exclusion criteria: does not apply
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis and presentation of patient characteristics, perioperative and postoperative parameters as well as oncological parameters. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Univariate and multivariate analysis for the identification of risk factors for the occurrence of recurrence and long-term oncological outcome - Subgroup analyses with respect to the underlying Tumor disease as well as the HIPEC regimen applied. - Survey of the postoperative quality of life (QoL) by means of a a specific questionnaire. | — |
Countries
Germany
Contacts
Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Universitätsklinikum Carl Gustav Carus der TU Dresden